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CLJNKALDETECTIONOFCARDIACALLOGRAFTRUECnON 
USING 31-P NMR SPECXROSCOPY 
William T. Evanochko, Alain Bouchard, James K 
Kirklin, Derek Luney, Katharine Kirk, Gerald M. Pohost, University of 
Alabama at Birmingham, Birmingham, AL 
The reliable noninvasive detection of acute cardiac allograft rejection 
remains an elusive goal. Since animal studies have demonstrated early 
changes in phosphocreatine (PCr)/adenosine- triphosphate {Al-P) ratio 
by P-31 NMR spectroscopy, we evaluated 11 patients with 37 serial 
studies beginning 3-S weeks after cardiac transplantation. In addition, 
eight volunteers were studied as controls. Image-guided localized P-31 
NMR spectroscopy was performed using a 1ST Philips Gyroscan with 
a selected volume of 7515Oc.c of the left veniricle. Histologic evaluation 
was used to categorize myocardial biopsies (performed within 24hrs of 
NMR analysis) into mild, moderate, or severe rejection using the 
Billingham criteria. 
The PCr/ATP’s for normal volunteers and non-rejecting transplants 
(mild histological) were 1.35 4 0.26 (SD) (n =S) and 0.95 &, .25 (.n=28) 
(p< .OOOl). A decrease in PCr/ATP was predictive of rejection 
(moderate or severe by histologic grade) within 2 weeks of the NI4R 
study. The mean PCr/ATP for the rejecting group was 0.83 + 0.10 
(n=16) compared to 1.00 f 0.25 (n=21) unassociated with rejection 
within 2 weeks (pc .Ol). Inferences: 
. The bioenergetics in the transplanted heart (reflected by the 
PCr/ATP) is significantly different from normal volunteers. 
- This preliminary clinical study suggests that P-31 NMR spectroscopy 
may allow the detection of acute cardiac rejection. 
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ASSESSMENT OF VENTRICULAR FUNCTION WITH THE 
MULTIWIRE GAMMA CAMERA AND TANTALUM-178 DURING 
PERCUTANEOUS TRANSLUMINAL CORONARY ANGIO- 
PLASTY 
! Jeffrey L. Lacy, Gerald W. Guidry, John J. 
Mahmarian, Shigeyuki Nishimura, Robert Roberts, Baylor 
College of Medicine, Houston, Texas 
The recently developed mobile multiwire gamma camera 
and the short-lived (T-1/2 = 9.3 minutes), generator-produced 
Isotope tantalum-178 provide rapid, serial assessment of re- 
gional and global ventricular function by first-pass radionuclide 
angi 
03 
raphy, at bedside, and thus for the first time enable the 
use o nuclear techniques to study the changes in LV and RV 
function during coronary angioplasty. Accordin ly, we 
performed first-pass radionuclide angiography at base ine and 9 
during 51 episodes of transient coronarv occlusions durina 
corotiary an ’ ioplasty, using the multiwire &mera and doses of 
up to 100 m 8 i of tantalum-178. Occlusion of the left anterior de- 
s&din 
-- -- -- 
ejection % 
(LAD) artery (n=23) caused severe be&eases in LV 
action (5503% to 32*10%, p=.OOl), 
ing rate (2.5tO.7 to 1 .ft0.6 EDV/sec, p= XXI01 !i 
eak diastolic fill- 
, LV dilation, fall 
in stroke volume and cardiac output indices. and severe anterior 
hypokinesis or akinesis (all pc &5). These changes were all 
more striking durin 
IAD arteries (n-2 B 
proximal LAD occlusion. Occlusion of non- 
canl than 
during LA % 
) caused regional dysfunction but insignifi- 
es in global LV function. 
(432 
RV ejection fraction fell 
to 39*9%, p<.O5), circumflex 
39i8%, p= .03), and proximal right coronary artery 
S&7%, p c .Ol) occlusions. Only the latter caused RV dilation. 
We conclude that the LV function is markedly depressed 
during transient balloon occlusion of the LAD, but not of non- 
LflD coronary arteries. RV function decreases during LAD, 
circumflex or proximal right coronary artery 
the latter causes ischemlc RV dilation. 
occlusions, but only 
IMYOSIN SC1 
EVALUATION OF 
ehiro Yasuda. James F. Southern. 
r F. Palacios. John B. Newell. G. Wilii 
William Strauss, Edgar Haber. 
Massachusetts Geieral Hospital. Boston. MA 
Fifty patients with no evidence of ischemic. valvular or congenital 
revealed 
chance-corrected a~~erne~t within observer 
good to excellent 
A I -A2. 
0.8410.14) and b;ween two observers (ka 
A2-8. 0.72fO. 14). EMB detected myocarditis or borderline 
myocarditis& 15 batients. AMS resu-hs revealed a high sensitivity 
($8f5%) and negative predictive value (83f5s) for th 
of myocarditis. although specificity was low (30f6%). 
to lung ratio (H/L) for the AM antibody uptake in biop 
AMS-positive cases (I .67&0.28) was essentially similar to that in 
AMS-positive, biopsy-negative cases ( 1.6 
possibility of identical underlying patholo 
sting the 
was 
significantly lower in biopsy- and AMS-negative patients 
(I .3 I *O. 18: p<O.OOl). A high sensitivity and negative predictive 
value with identical HIL in concordant and discordant positive 
hMS suggests that nonspecific uptake of AM antibody 
likely and that AMS may in fact detect myocarditis tha 
failed to detect. The study highlights a methodological m 
of using an established standard of unproven 
evaluation of a new dia 
sensitivity for the 
higher sensitivity than t b 
nostic test. since a comparison test 
e 
specificity. 
standard may be deemed to have 
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NONINVASIVE IMAGING OF CARC:At TRANSPLAf’JTATlON REJECTION 
IN PRIMATES USING TWO NE\PI ANTIML\%IN IMAGING AGENTS 
Roberl A.Vaccarino, Juan E. Sanchez, Lynne L.Johnson, Theodore 
S.T.Wang,David W. Seldin, Charles e. Patrick E@e, Ketan Bhatia. 
Eric A. Rose, Ban A. Khaw, Columbia University, N.Y., N.Y. 
Indiurn-111 labeled rnonoclonal antimyosin Fab (using DTPA 
chelate)(AMFab) has been used to image myocardial infarction and 
transplant rejection with localization only in myocardial eells that have 
suffered irreversible loss of cell membrane integrity. Potential technical 
limitations are dosimetry, limited by 72 hr hatf life of In-1 11, stow blood 
clearance delaying optimal imaging to 24 -46 hrs after fnjection and hepatic 
uptake. Therefore 2 new AM imaging agents, polylysine In-IllAM 
(0.023mgFab modified with a 3.3kd polymer of PLA and labeled with In-l 11 
) ardTc-99m AM (0.5mg Fab’ AM labeled using the RP-1 ligand technique, 
Centocor ) were compared in 6 primates, 5 having undergone heterotopic 
xerographic (2) or orthotopic albgraphic (3) transplantation. Each animal 
was injected first wiih 12-23 mCi Tc-99mAM and after comletion of imaging 
injected with 0.72-1.66 mCi In-l 11PLA and reimagnd. Biexponential 
curves were fit to the blood sample data and rate constants were 
determined and expressed as Tl12 values. The initial clearance for Tc- 
99mAM was more rapid than for In-1llPLA (T1/2 2.2 f1.7 min.vs 
7.7k12.0 min) but there was no significant difference between fate slow 
components (9.9i2.6 vs 7.7k 3.4hrs.). Planar imaging was performed at 
a mean of 18 hr pos r the In-l 11PLA and (at a mean of 6.5 hr 
postinjection for the . One normal animal was injected and 
imaged at corresponding time rnterwals and showed no bbod pool activity. 
Heart to lung oount ratios for In-111PLA and Tc-99mAM ranged from1.30- 
2.6 respectively and correlated with pathology scores (modiiied Billingham 
score) which ranged fmm 1.54 to 2.0. 
In conclusion both AM compounds show pror. se as agents for 
cardiac transplantation rejectiin within 24 hn of injection in man. 
imaging 
